MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Medical Imaging (Molecular, Functional-PET, Gamma & Nuclear Medicine) Company
Enlyton Ltd
Attachments
www.kthnschedule.com
Untitled
Parents
*Architects: Cancer & Oncology Companies_Diagnostics, Treatment, Health IT
*Architects: Medical Imaging (Molecular, Functional-PET, Gamma & Nuclear Medicine) Company
*Industry: Ohio
Children
CEO Jeff Bergen
Columbus, Ohio
CT and FDG-based PET/CT scans are the primary methods of imaging used in oncology today.
Current medical practices in oncology are limited in providing physicians with cancer-specific information.
Enlyton recognizes that cancer imaging should enable more definitive interpretation.
Enlyton technology improves molecular imaging by providing cancer-specific images that more accurately reflect the extent of disease.
It is difficult to differentiate between “possible” tumor areas and normal tissue.
Ohio molecular imaging firm hopes to improve cancer detection (2010)
Resultant images can be confusing.
These scans often fail to provide accurate information.